Market Research Industry Today
Cancer Diagnostics Market expected to grow at a CAGR of 7.6% during the forecast period of 2014 to 2020-Transparency Market Research
A new market report published by Transparency Market Research is Cancer Diagnostics Market (Tumor Biomarker Tests, Imaging, Endoscopy and Biopsy) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2020
Published 29 September 2015
The Global cancer diagnostics market is expected to grow at a CAGR of 7.6% during the forecast period of 2014 to 2020. In 2013, the global cancer diagnostics market was valued at US$100,994.5 million and is expected to be worth US$168,649.3 million by 2020.The increasing prevalence of cancer is the primary factor driving the global cancer diagnostics market. According to the WHO, the number of new cancer cases is projected to grow by approximately 70% in the next two decades. The rapidly growing number of cancer cases will fuel the growth of several sectors related to cancer diagnostics. According to method, the global cancer diagnostics market is divided into tumor biomarker tests, endoscopy, imaging, and biopsy. The segment of cancer imaging diagnosis is anticipated to grow at a CAGR of 8.2% during the forecasting horizon.
Imaging for cancer diagnosis has taken center stage in worldwide efforts aimed at cancer detection and prevention. Advanced diagnostics methods have achieved a reduction of 30% in mortality due to breast cancer. Hence, the imaging sector in the global cancer diagnostics market will continue its dominance in the foreseeable future.Application-wise, the global cancer diagnostics market is segmented into blood cancer, kidney cancer, colorectal cancer, breast cancer, prostate cancer, pancreatic cancer, ovarian cancer, lung cancer, and liver cancer. The global cancer diagnostics market is mostly driven by the growing demand for lung cancer, breast cancer, and colorectal cancer diagnosis. The lung cancer segment is leading the market, as it is the most common type of cancer.
Approximately 1.8 billion new cases of lung cancer were diagnosed in 2012.Geographically, the global cancer diagnostics market is segmented into North America, Asia Pacific, Europe, and Rest of the World (RoW). North America is the leading region in the global cancer diagnostics market. This regional market held a market share of 40.7% in the 2013 global cancer diagnostics market. The next region in the global cancer diagnostics market’s regional hierarchy is Europe, which held a 29.1% share in the global cancer diagnostics market in 2013.Asia Pacific will grow at the fastest CAGR of 8.2%, while North America will register a growth at a 7.0% CAGR during the forecasting horizon. The Asia Pacific cancer diagnostics market is driven by the increasing prevalence of breast cancer in this region. The RoW market for cancer diagnostics will also register good growth in the foreseeable future due to the increasing incidence of lung cancer.
Browse the full Cancer Diagnostics Market (Tumor Biomarker Tests, Imaging, Endoscopy and Biopsy) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2020 - 2020 report at http://www.transparencymarketresearch.com/cancer-diagnostics-market.html
It is easier to receive regulatory approval for in-vitro cancer diagnostics in Europe as compared to the U.S., hence many companies are launching their products in Europe. Market players in the global cancer diagnostics market offer molecular diagnostic products, in-vitro diagnostic products, and imaging platforms. The top imaging equipment manufacturers are Siemens, GE Healthcare, and Philips Healthcare. The key vendors of oncology diagnostics tests and related products include Abbott Diagnostics, Roche, Myriad Genetics, Ambry Genetics, AstraZeneca, Eli Lily Company, and Pfizer.
About Us
Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.
TMR’s data repository is continuously updated and revised by a team of research experts so that it always reflects the latest trends and information. With extensive research and analysis capabilities, Transparency Market Research employs rigorous primary and secondary research techniques to develop distinctive data sets and research material for business reports.
Contact
Mr. Nachiket
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Share on Social Media
Contact Information
Mr. Rohit Bhisey
Transparency Market Research
State Tower, 90 State Street,
Suite 700,
Albany
12207
+91- 8600924083
http://www.transparencymarketresearch.com/
Other Industry News
Ready to start publishing
Sign Up today!
